Malignant neoplasm of stomach, unspecified
Conditions
Interventions
The study is case control and was performed on 2 occasions and in two groups: one before the start of chemotherapy (QT) with study group (with 21 participants receveing platinum derivatives) and one
for the control group (with 22 health participants), 2 evaluations were performed at the Clinical Research Unit (UPC), with taste tests to evaluate sweet, salty, sour and bitter tastes and food sample
Behavioural
Dietary supplement
C10.597.751.861
E01.370.600.425
Sponsors
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP
Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Study group: over 18 years of age; undergoing QTX with platinum compounds at the Chemotherapy Center. Control Group: 18 years; healthy; group formed by the companions of patients.
Exclusion criteria
Exclusion criteria: Smoking subjects, submitted to radiotherapy, with oral lesions, allergic to the test product (cream cheese and monosodium glutamate)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcome is characterized by taste changes;taste alterations are a consequence of the disease and the treatment, which influence the food intake and bring repercussion in the nutritional status of patients submitted to chemotherapy with platinum drugs | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes could be observed before the onset of the disease, due to the inflammatory process associated with cancer;taste alterations are a consequence of the disease and the treatment, which influence the food intake and bring repercussion in the nutritional status of patients submitted to chemotherapy with platinum derivatives | — |
Countries
Brazil
Contacts
Public ContactJuliana Sicchieri
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP
Outcome results
None listed